Cite
HARVARD Citation
Pinto-Mariz, F. et al. (2015). CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy. Skeletal muscle. 5 (1), pp. 1-10. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pinto-Mariz, F. et al. (2015). CD49d is a disease progression biomarker and a potential target for immunotherapy in Duchenne muscular dystrophy. Skeletal muscle. 5 (1), pp. 1-10. [Online].